Milestones/Time Lines (From Sanguine's business plan)
1-6 months. Preform preliminary gross animal tests
6-12 months. Conduct animal safety and efficacy trials. Make strategic Alliance with large pharmaceutical firm.
12-30 months. A. Simultaneously prepare IND applications for European and United States FDA approvals, revive clinical trials with Italian Red Cross and Health Ministry,Erasmun University, Rotterdam, et al.
B. Conduct trials for cardioplegia, cancer and cardiology in United States, but transfusion elsewhere.
30-33 months Submit license applications to Italian, Dutch, et al. Begin production as Subcontractors.
33-36 months. A. Submit United States New Drug Application (NDA).
B. Begin sales in Italy, Holland and other countries which accept their drug approvals.
36 A. Begin United States and Canada sales for cancer and PTCA. Continue trials on other applications, transplant organ preservation, Co poisoning, sickle cell anemia, stroke and heart attack, et al.
Welcome to the board
|
